Suspect multidrug-resistant gram-negative urinary tract infection in patients with a history of any of the following in the prior three months: |
|
|
|
|
NOTE: The predictive value of these risk factors for multidrug-resistant gram-negative urinary tract infections has not been systematically evaluated. In particular, the time interval since these exposures is not well validated. The threshold for empirically covering a multidrug-resistant infection varies with the severity of infection, with a lower threshold warranted for more severe disease. |
* This includes a single antibiotic dose given for prophylaxis prior to prostate procedures.
¶ The prevalence of multidrug resistance is not well documented in all parts of the world. Some countries where the prevalence is particularly high include India, Israel, Spain, and Mexico.Do you want to add Medilib to your home screen?